Connplex Cinemas Ltd. IPO Sees Strong Investor Buzz — NSE SME Listing on August 14

Connplex Cinemas Ltd., a leading player in the regional multiplex cinema business, has opened its ₹90.27 crore SME IPO for subscription on August 7, 2025, with overwhelming investor interest continuing through the bidding period. The issue closed on August 11, 2025, and is set to list on NSE SME platform on August 14, 2025.

IPO Details at a Glance

• IPO Opening Date: 7 August 2025

• IPO Closing Date: 11 August 2025

• Price Band: ₹168 – ₹177 per share

• Issue Size: ₹90.27 crore (Fresh issue of 51 lakh equity shares)

• Lot Size: 800 shares

• Minimum Investment (Retail): ₹2.83 lakh (2 lots)

• Listing: NSE SME

• Allotment Date: 12 August 2025

Subscription Status

The IPO was a huge success, recording heavy oversubscription across categories:

• Retail Investors: 24.78x

• HNI/NII: 37.06x

• QIB: 44.21x

• Overall Subscription: 33.25x

This high demand reflects growing investor confidence in the regional entertainment sector and Connplex Cinemas’ expansion plans.

Grey Market Premium (GMP) Trends

• On launch day, GMP stood around ₹31, indicating strong listing expectations.

• By allotment date, GMP cooled to around ₹13, still suggesting a possible listing near ₹190, around 7% premium to the upper price band.

Company Overview

Connplex Cinemas operates a chain of modern multiplexes catering to tier-2 and tier-3 cities, offering an enhanced cinema experience with advanced technology, superior seating, and premium amenities. The company focuses on delivering regional language content along with mainstream cinema to tap into the growing local entertainment demand.

Use of IPO Proceeds

• Setting up new multiplex screens across Gujarat and other states.

• Upgrading projection & sound systems.

• Repayment of certain borrowings.

• General corporate purposes.

Market Outlook

With the Indian multiplex sector seeing a revival post-pandemic, smaller regional players like Connplex Cinemas are attracting attention for their low penetration markets and higher growth potential. The IPO’s robust subscription numbers and decent GMP indicate a healthy debut, though long-term performance will depend on operational expansion and consistent occupancy levels.

Key Dates

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their financial advisor before making any investment decisions.